Clinical Validation of Unani Pharmacopoeal formulation Jawarish-e-Bisbasa in cases of Saman e Mufrit (Central Obesity)

Central Council for Research in Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients of Saman Mufrit (Central Obesity) presenting with the following:
•1 BMI Male equal to or less than 34.99 kg/m2 and Female equal to or less than 32.49 kg/m2)
•2 Waist Circumference (more than 94cms in Males and more than 80 cms in Females)
•3 Waist â?? to â?? hip ratio between (more than 80cm to less than 1m), (Female 80 to 85 and male more than 90cm to less than 1m)
•4 Saggital Abdominal Diameter (SAD) more than 25 cms
•5 Patients presenting with central obesity with or without following complaints:
•I.Heart burn
•II.Fullness of stomach
•III.Breathing difficulties
•IV.Sleep apnea

•1.Medications causing secondary weight gain e.g.Phenothiazines, sodium valproate, carbamazepine, lithium, glucocorticoids, thiazolidinedioneâ??s, sulphonylureas, adrenergic antagonists, etc
•2.Patient on Oral contraceptive pills or Hormone Replacement therapy
•3.Patient having systemic illness requiring long term treatment
•4.Patients unable to exercise
•5.Pregnant and lactating females

发起方